The Diabetes Therapies section of Frontiers in Clinical Diabetes and Healthcare publishes high-quality review articles and clinical and epidemiological research across all aspects relating to diabetes therapies.
Areas covered by this section include, but are not limited to:
· Novel antidiabetic drugs
· Cost relating to diabetes therapies
· Adverse effects and complications
· Drug delivery system
· Glucose monitoring devices
· Treatment guidelines
· Clinical trials
· Current therapeutic status
· Healthcare system
All studies must contribute insights into clinical or epidemiological aspects relating to diabetes therapies. Reports dealing with basic, molecular or translational aspects do not fall within the scope of this section and should be submitted to more specialized journals. This section operates in close collaboration with our sister journal, Frontiers in Endocrinology.
Indexed in: CLOCKSS, CrossRef, DOAJ, Google Scholar, OpenAIRE
Diabetes Therapies welcomes submissions of the following article types: Brief Research Report, Case Report, Classification, Clinical Trial, Community Case Study, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Policy Brief, Review, Study Protocol, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Diabetes Therapies, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com